Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | (4-Methoxyphenyl)boronic acid | HCID 201262 | — |
| Reactant | HCID 67216898 | HCID 67216898 | — |
| Catalyst | Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+) | HCID 178418228 | — |
| Solvent | Water 1,2-dimethoxyethane | HCID 18180031 | — |
| Product | HCID 67216242 | HCID 67216242 | 95% |
Reaction Steps
To a solution of 4-[(5R,7S)-7-(4-bromo-phenyl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluoro-benzonitrile (25 mg, 63 μmol) in DME:H2O (4:1, 1 ml) were added Na2CO3 (10 mg, 94 μmol) and 4-methoxyphenylboronic acid (10.5 mg, 69 μmol). To this stirred mixture, PdCl2(dppf).CH2Cl2 complex (1.03 mg, 1.26 μmol) was added. The reaction was carried out under sealed-vessel microwave heating at 120° C. for 10 minutes using a Biotage Initiator™ (pre-stirring: 10 s, absorption level: very high). Upon completion, the mixture was allowed to cool to room temperature, the Pd catalyst was filtered off and the solvent was removed. The crude product obtained was purified using preparative LC-MS and lyophilized to give 3-fluoro-4-[(5R,7S)-7-hydroxy-7-(4′-methoxy-biphenyl-4-yl)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-benzonitrile (13 mg, >95% purity). MS 426.0 (M+H), LCMS condition C, retention time 2.06 min. 1H NMR (600 MHz, DMSO-d6) δ ppm 2.90 (dd, 1H), 3.43-3.48 (m, 1H), 3.78 (s, 3H), 6.17 (dd, 1H), 6.59 (br. s., 1H), 7.01-7.03 (m, 2H), 7.33 (t, 1H), 7.53 (d, 2H), 7.60-7.62 (m, 2H), 7.63-7.65 (m, 2H), 7.78 (dd, 1H), 8.02 (dd, 1H), 8.94 (br. s., 1H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08575160B2 |
|---|
| Source dataset | uspto-grants-2013_11 |
|---|
| ORD ID | ord-b76ceb6ba80b4b089942a83fef5136a7 |
|---|
| Source note | uspto-grants-2013_11 |
|---|